319 related articles for article (PubMed ID: 8366661)
1. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
Matsuda Y
Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661
[TBL] [Abstract][Full Text] [Related]
2. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
Matsuda Y; Hirata K; Inoue N; Suematsu M; Kawashima S; Akita H; Yokoyama M
Circ Res; 1993 May; 72(5):1103-9. PubMed ID: 8477522
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoprotein inhibits acetylcholine-induced vasorelaxation and increases 5-HT-induced vasoconstriction in isolated human saphenous vein.
Zhao L; Tackett RL
J Pharmacol Exp Ther; 1998 Feb; 284(2):637-43. PubMed ID: 9454809
[TBL] [Abstract][Full Text] [Related]
4. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins.
Kugiyama K; Kerns SA; Morrisett JD; Roberts R; Henry PD
Nature; 1990 Mar; 344(6262):160-2. PubMed ID: 2106627
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium.
Galle J; Schollmeyer P; Wanner C
Eur Heart J; 1993 Nov; 14 Suppl I():111-7. PubMed ID: 8293762
[TBL] [Abstract][Full Text] [Related]
6. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
[TBL] [Abstract][Full Text] [Related]
7. Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein.
Cox DA; Cohen ML
J Pharmacol Exp Ther; 1996 Mar; 276(3):1095-103. PubMed ID: 8786540
[TBL] [Abstract][Full Text] [Related]
8. Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids.
Lewis TV; Dart AM; Chin-Dusting JP
Cardiovasc Res; 1997 Jun; 34(3):590-6. PubMed ID: 9231043
[TBL] [Abstract][Full Text] [Related]
9. Regulation of endothelial cell protein C activation by native and oxidized low density lipoprotein.
Wilson BD; Pitas RE; Rodgers GM
Semin Thromb Hemost; 1992 Jan; 18(1):11-7. PubMed ID: 1574712
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
Kobayashi T; Matsumoto T; Kamata K
Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxidized low density lipoprotein on nitric oxide synthetase and protein kinase C activities in bovine endothelial cells.
Mukherjee S; Coaxum SD; Maleque M; Das SK
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1051-8. PubMed ID: 11785656
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of 17 beta-estradiol on endothelial function injured by oxidized low-density lipoproteins.
Peng CF; Li YJ; Deng HW; Xiong XM
Zhongguo Yao Li Xue Bao; 1996 May; 17(3):252-5. PubMed ID: 9812750
[TBL] [Abstract][Full Text] [Related]
13. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation.
Keaney JF; Guo Y; Cunningham D; Shwaery GT; Xu A; Vita JA
J Clin Invest; 1996 Jul; 98(2):386-94. PubMed ID: 8755649
[TBL] [Abstract][Full Text] [Related]
14. Native and oxidized low-density lipoproteins modulate the vasoactive actions of soluble beta-amyloid peptides in rat aorta.
Smith CC; Stanyer L; Betteridge DJ; Cooper MB
Clin Sci (Lond); 2007 Dec; 113(11):427-34. PubMed ID: 17531005
[TBL] [Abstract][Full Text] [Related]
15. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
[TBL] [Abstract][Full Text] [Related]
16. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein.
Vasques E; Almeida AL; Noya V; D'Alegria B; Marathe G; McIntyre TM; Tibiriçá E; Bozza PT; Silva AR; Castro-Faria-Neto HC
Endothelium; 2006; 13(1):1-8. PubMed ID: 16885061
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta.
Wong WT; Ng CH; Tsang SY; Huang Y; Chen ZY
Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):157-64. PubMed ID: 20005687
[TBL] [Abstract][Full Text] [Related]
18. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.
Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M
Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684
[TBL] [Abstract][Full Text] [Related]
19. Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation.
Brindisi MC; Duvillard L; Monier S; Vergès B; Perségol L
Diabetes Metab Res Rev; 2013 Nov; 29(8):618-23. PubMed ID: 23908137
[TBL] [Abstract][Full Text] [Related]
20. Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoprotein.
Galle J; Bengen J; Schollmeyer P; Wanner C
Eur J Pharmacol; 1994 Nov; 265(1-2):111-5. PubMed ID: 7883023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
